Literature DB >> 33368373

Evaluation of SARS-CoV-2 antibody titers and potency for convalescent plasma donation: a brief commentary.

Elise Wouters1, Maurice Steenhuis2, Hubert Schrezenmeier3,4, Pierre Tiberghien5,6, Heli Harvala7, Hendrik B Feys1, Ellen van der Schoot2.   

Abstract

Entities:  

Keywords:  COVID-19; ELISA; SUPPORT-E; convalescent plasma; neutralization

Year:  2020        PMID： 33368373     DOI： 10.1111/vox.13060

Source DB:  PubMed          Journal:  Vox Sang        ISSN： 0042-9007            Impact factor:   2.144


× No keyword cloud information.
  6 in total

1.  Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19.

Authors:  Sixten Körper; Manfred Weiss; Daniel Zickler; Thomas Wiesmann; Kai Zacharowski; Victor M Corman; Beate Grüner; Lucas Ernst; Peter Spieth; Philipp M Lepper; Martin Bentz; Sebastian Zinn; Gregor Paul; Johannes Kalbhenn; Matthias M Dollinger; Peter Rosenberger; Thomas Kirschning; Thomas Thiele; Thomas Appl; Benjamin Mayer; Michael Schmidt; Christian Drosten; Hinnerk Wulf; Jan Matthias Kruse; Bettina Jungwirth; Erhard Seifried; Hubert Schrezenmeier
Journal:  J Clin Invest       Date:  2021-10-15       Impact factor: 14.808

2.  International Forum on the Collection and Use of COVID-19 Convalescent Plasma: Responses.

Authors:  Arwa Z Al-Riyami; Thierry Burnouf; Mark Yazer; Darrell Triulzi; Levent Tufan Kumaş; Levent Sağdur; Nil Banu Pelit; Renée Bazin; Salwa I Hindawi; Maha A Badawi; Gopal K Patidar; Hem Chandra Pandey; Rahul Chaurasia; Roberta Maria Fachini; Patrícia Scuracchio; Silvano Wendel; Ai Leen Ang; Kiat Hoe Ong; Pampee Young; Jarkko Ihalainen; Antti Vierikko; Yan Qiu; Ru Yang; Hua Xu; Naomi Rahimi-Levene; Eilat Shinar; Marina Izak; Carlos Alberto Gonzalez; David Martin Ferrari; Paula Verónica Cini; Robby Nur Aditya; Ratti Ram Sharma; Suchet Sachdev; Rekha Hans; Divjot Singh Lamba; Lise Sofie H Nissen-Meyer; Dana V Devine; Cheuk Kwong Lee; Jennifer Nga-Sze Leung; Ivan Fan Ngai Hung; Pierre Tiberghien; Pierre Gallian; Pascal Morel; Khuloud Al Maamari; Zaid Al-Hinai; Hans Vrielink; Cynthia So-Osman; Vincenzo De Angelis; Pierluigi Berti; Angelo Ostuni; Giuseppe Marano; Michel Toungouz Nevessignsky; Magdy El Ekiaby; James Daly; Veronica Hoad; Sinyoung Kim; Karin van den Berg; Marion Vermeulen; Tanya Nadia Glatt; Richard Schäfer; Rita Reik; Richard Gammon; Melissa Lopez; Lise Estcourt; Sheila MacLennan; David Roberts; Vernon Louw; Nancy Dunbar
Journal:  Vox Sang       Date:  2021-05-20       Impact factor: 2.996

3.  Persistence of SARS-CoV-2 total immunoglobulins in a series of convalescent plasma and blood donors.

Authors:  M Carmen Martin; Ana Jimenez; Nuria Ortega; Alba Parrado; Isabel Page; M Isabel Gonzalez; Lydia Blanco-Peris
Journal:  PLoS One       Date:  2022-02-24       Impact factor: 3.240

Review 4.  Commentary: Convalescent plasma to treat COVID-19: Following the Argentinian lead.

Authors:  Pierre Tiberghien; Eric Toussirot; Pascale Richard; Pascal Morel; Olivier Garraud
Journal:  Transfus Apher Sci       Date:  2021-05-23       Impact factor: 1.764

5.  Qualifying coronavirus disease 2019 convalescent plasma donors in Israel.

Authors:  Marina Izak; Veronica Gendelman; Sharron Bransburg-Zabary; Evgeniy Stoyanov; Roni Gat; Daniel Cohen; Jacob Chen; Yasmin Maor; Avi Benov; Boaz Lev; Oren Zimhony; Eilat Shinar
Journal:  Vox Sang       Date:  2021-06-14       Impact factor: 2.996

6.  Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies.

Authors:  Sixten Körper; Bernd Jahrsdörfer; Victor M Corman; Jan Pilch; Patrick Wuchter; Rainer Blasczyk; Rebecca Müller; Torsten Tonn; Tamam Bakchoul; Richard Schäfer; David Juhl; Tatjana Schwarz; Nina Gödecke; Thomas Burkhardt; Michael Schmidt; Thomas Appl; Hermann Eichler; Harald Klüter; Christian Drosten; Erhard Seifried; Hubert Schrezenmeier
Journal:  Transfus Med Hemother       Date:  2021-04-21       Impact factor: 3.747
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.